Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$2.48M Sell
105,052
-22,497
-18% -$539K ﹤0.01% 2698
2014
Q2
$3.11M Buy
127,549
+7,702
+6% +$180K ﹤0.01% 2436
2014
Q1
$2.84M Buy
119,847
+15,309
+15% +$372K ﹤0.01% 2423
2013
Q4
$2.63M Buy
104,538
+22,263
+27% +$525K ﹤0.01% 2540
2013
Q3
$1.9M Sell
82,275
-14,916
-15% -$340K ﹤0.01% 2647
2013
Q2
$1.99M Buy
+97,191
New +$1.84M ﹤0.01% 2554

Other funds holding SNV

UBS's SNV Position: Q3 2014 in Review

UBS reduced its Synovus (SNV) stake by 18% in Q3 2014, selling an estimated $539K and leaving 105,052 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

UBS first reported a position in SNV in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.11M in Q2 2014. 235 funds tracked by Wall St. Rank hold SNV as of Q3 2014.

  • UBS held 105,052 shares of Synovus worth $2.48M as of Q3 2014.
  • UBS sold 22,497 Synovus shares in Q3 2014, an estimated $539K.
  • Synovus made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2698 holding.
  • UBS first reported a position in Synovus in Q2 2013 and has held it in 6 quarters since.
  • UBS's Synovus position peaked at $3.11M in Q2 2014.
  • 235 funds tracked by Wall St. Rank held Synovus as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.